MassMutual Private Wealth & Trust FSB boosted its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 3.3% in the 4th quarter, HoldingsChannel reports. The firm owned 4,187 shares of the company’s stock after buying an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB’s holdings in Colgate-Palmolive were worth $381,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in CL. State Street Corp increased its holdings in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC increased its holdings in Colgate-Palmolive by 2.8% during the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after purchasing an additional 557,492 shares during the last quarter. Legal & General Group Plc boosted its stake in Colgate-Palmolive by 0.8% in the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock worth $755,465,000 after purchasing an additional 61,413 shares in the last quarter. Finally, Barclays PLC increased its stake in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares in the last quarter. 80.41% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on CL shares. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Finally, Barclays decreased their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $101.11.
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.37% of the stock is owned by insiders.
Colgate-Palmolive Stock Performance
Shares of Colgate-Palmolive stock opened at $87.53 on Thursday. Colgate-Palmolive has a 12 month low of $80.03 and a 12 month high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $71.51 billion, a PE ratio of 25.08, a PEG ratio of 3.64 and a beta of 0.44. The stock’s fifty day simple moving average is $92.07 and its 200 day simple moving average is $97.65.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- What Are Dividend Achievers? An Introduction
- Oracle Announces Game-Changing News for the AI Industry
- What is the NASDAQ Stock Exchange?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Using the MarketBeat Stock Split Calculator
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.